Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
stephen russell
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Procedures
Disorders
Anatomy
Sign-in to see full Profile
Network (preview)
36
Peng, Kah-Whye
23
Cosset, François-Loïc
16
Dispenzieri, Angela
15
Greipp, Philip
15
Dingli, David
12
Witzig, Thomas
12
Gertz, Morie
12
Galanis, Evanthia
12
Rajkumar, Vincent
11
Hayman, Suzanne
11
Lacy, Martha
11
Greiner, Suzanne
11
Cattaneo, Roberto
11
Zeldenrust, Steven
10
Kyle, Robert
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of stephen russell (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Liu Chunsheng; Hasegawa Kosei; Russell Stephen J; Sadelain Michel; Peng Kah-Whye
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.
The Prostate 2009;69(10):1128-41.
-
2009: Kapoor Prashant; Kumar Shaji; Fonseca Rafael; Lacy Martha Q; Witzig Thomas E; Hayman Suzanne R; Dispenzieri Angela; Buadi Francis; Bergsagel P Leif; Gertz Morie A; Dalton Robert J; Mikhael Joseph R; Dingli David; Reeder Craig B; Lust John A; Russell Stephen J; Roy Vivek; Zeldenrust Steven R; Stewart A Keith; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
-
2009: Ong Hooi Tin; Trejo Theodore R; Pham Linh D; Oberg Ann L; Russell Stephen J; Peng Kah-Whye
Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(6):1012-21.
-
2009: Ng A C; Kumar S K; Russell S J; Rajkumar S V; Drake M T
Dexamethasone and the risk for adrenal suppression in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(5):1009-11.
-
2009: Pham Linh; Nakamura Takafumi; Gabriela Rosales A; Carlson Stephanie K; Bailey Kent R; Peng Kah-Whye; Russell Stephen J
Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome.
The journal of gene medicine 2009;11(3):197-206.
-
2009: Msaouel Pavlos; Iankov Ianko D; Allen Cory; Morris John C; von Messling Veronika; Cattaneo Roberto; Koutsilieris Michael; Russell Stephen J; Galanis Evanthia
Engineered measles virus as a novel oncolytic therapy against prostate cancer.
The Prostate 2009;69(1):82-91.
-
2009: Russell S J; Peng K W
Measles virus for cancer therapy.
Current topics in microbiology and immunology 2009;330():213-41.
-
2008: Frecha Cecilia; Costa Caroline; Nègre Didier; Gauthier Emmanuel; Russell Stephen J; Cosset François-Loïc; Verhoeyen Els
Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
Blood 2008;112(13):4843-52.
-
2008: Kelly Elizabeth J; Hadac Elizabeth M; Greiner Suzanne; Russell Stephen J
Engineering microRNA responsiveness to decrease virus pathogenicity.
Nature medicine 2008;14(11):1278-83.
-
2008: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Kumar Shaji; Kyle Robert A; Fonseca Rafael; Greipp Phillip R; Lust John A; Rajkumar Vincent S; Hayman Suzanne R; Buadi Francis; Russell Stephen J; Zeldenrust Stephen R; Dispenzieri Angela
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
American journal of hematology 2008;83(11):840-1.
-
2008: Allen Cory; Paraskevakou Georgia; Iankov Ianko; Giannini Caterina; Schroeder Mark; Sarkaria Jann; Schroeder Mark; Puri Raj K; Russell Stephen J; Galanis Evanthia
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(9):1556-64.
-
2008: Russell Stephen J; Peng Kah Whye
The utility of cells as vehicles for oncolytic virus therapies.
Current opinion in molecular therapeutics 2008;10(4):380-6.
-
2008: Liu C; Erlichman C; McDonald C J; Ingle J N; Zollman P; Iankov I; Russell S J; Galanis E
Heat shock protein inhibitors increase the efficacy of measles virotherapy.
Gene therapy 2008;15(14):1024-34.
-
2008: Blechacz B; Russell S J
Measles virus as an oncolytic vector platform.
Current gene therapy 2008;8(3):162-75.
-
2008: Leung N; Gertz M A; Zeldenrust S R; Rajkumar S V; Dispenzieri A; Fervenza F C; Kumar S; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Hayman S R; Russell S J; Kyle R A; Winters J L
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Kidney international 2008;73(11):1282-8.
-
2008: Miyagi Naoto; Rao Vinay P; Ricci Davide; Du Zeji; Byrne Guerard W; Bailey Kent R; Nakai Hiroyuki; Russell Stephen J; McGregor Christopher G A
Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(5):554-60.
-
2008: Munguia A; Ota T; Miest T; Russell S J
Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.
Gene therapy 2008;15(10):797-806.
-
2008: Bajzer Zeljko; Carr Thomas; Josic Kresimir; Russell Stephen J; Dingli David
Modeling of cancer virotherapy with recombinant measles viruses.
Journal of theoretical biology 2008;252(1):109-22.
-
2008: Kumar Shaji K; Rajkumar S Vincent; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Buadi Francis K; Zeldenrust Steven R; Dingli David; Russell Stephen J; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Improved survival in multiple myeloma and the impact of novel therapies.
Blood 2008;111(5):2516-20.
-
2008: Ricci Davide; Mennander Ari A; Pham Linh D; Rao Vinay P; Miyagi Naoto; Byrne Guerard W; Russell Stephen J; McGregor Christopher G A
Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2008;33(1):32-9.
-
2007: Rao Vinay P; Miyagi Naoto; Ricci Davide; Carlson Stephanie K; Morris John C; Federspiel Mark J; Bailey Kent R; Russell Stephen J; McGregor Christopher G A
Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation.
Transplantation 2007;84(12):1662-6.
-
2007: Rao Vinay P; Branzoli Stefano E; Ricci Davide; Miyagi Naoto; O'Brien Timothy; Tazelaar Henry D; Russell Stephen J; McGregor Christopher G A
Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(12):1281-5.
-
2007: Liu Chunsheng; Sarkaria Jann N; Petell Cory A; Paraskevakou Georgia; Zollman Paula J; Schroeder Mark; Carlson Brett; Decker Paul A; Wu Wenting; James C David; Russell Stephen J; Galanis Evanthia
Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7155-65.
-
2007: Myers R M; Greiner S M; Harvey M E; Griesmann G; Kuffel M J; Buhrow S A; Reid J M; Federspiel M; Ames M M; Dingli D; Schweikart K; Welch A; Dispenzieri A; Peng K-W; Russell S J
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.
Clinical pharmacology and therapeutics 2007;82(6):700-10.
-
2007: Hasegawa Kosei; Hu Chunling; Nakamura Takafumi; Marks James D; Russell Stephen J; Peng Kah-Whye
Affinity thresholds for membrane fusion triggering by viral glycoproteins.
Journal of virology 2007;81(23):13149-57.
-
2007: Lacy Martha Q; Gertz Morie A; Dispenzieri Angela; Hayman Suzanne R; Geyer Susan; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Bergsagel P Leif; Stewart A Keith; Rajkumar S Vincent
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1179-84.
-
2007: Dingli D; Russell S J
Mouse models and the RANKL/OPG axis in myeloma bone disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(10):2090-3.
-
2007: Goel Apollina; Carlson Stephanie K; Classic Kelly L; Greiner Suzanne; Naik Shruthi; Power Anthony T; Bell John C; Russell Stephen J
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.
Blood 2007;110(7):2342-50.
-
2007: Waehler Reinhard; Russell Stephen J; Curiel David T
Engineering targeted viral vectors for gene therapy.
Nature reviews. Genetics 2007;8(8):573-87.
-
2007: Russell Stephen J; Peng Kah-Whye
Viruses as anticancer drugs.
Trends in pharmacological sciences 2007;28(7):326-33.
-
2007: Schirmer Johannes M; Miyagi Naoto; Rao Vinay P; Ricci Davide; Federspiel Mark J; Kotin Robert M; Russell Stephen J; McGregor Christopher G A
Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(6):550-7.
-
2007: Paraskevakou Georgia; Allen Cory; Nakamura Takafumi; Zollman Paula; James C David; Peng Kah Whye; Schroeder Mark; Russell Stephen J; Galanis Evanthia
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(4):677-86.
-
2007: Kelly Elizabeth; Russell Stephen J
History of oncolytic viruses: genesis to genetic engineering.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(4):651-9.
-
2007: Dispenzieri Angela; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael; Lacy Martha Q; Bergsagel P Leif; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Reeder Craig B; Lust John A; Russell Stephen J; Hayman Suzanne R; Roy Vivek; Kumar Shaji; Zeldenrust Steven R; Dalton Robert J; Stewart A Keith
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):323-41.
-
2007: Carlson Stephanie K; Classic Kelly L; Bender Claire E; Russell Stephen J
Small animal absorbed radiation dose from serial micro-computed tomography imaging.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(2):78-82.
-
2007: Haralambieva Iana; Iankov Ianko; Hasegawa Kosei; Harvey Mary; Russell Stephen J; Peng Kah-Whye
Engineering oncolytic measles virus to circumvent the intracellular innate immune response.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(3):588-97.
-
2007: Stewart A K; Bergsagel P L; Greipp P R; Dispenzieri A; Gertz M A; Hayman S R; Kumar S; Lacy M Q; Lust J A; Russell S J; Witzig T E; Zeldenrust S R; Dingli D; Reeder C B; Roy V; Kyle R A; Rajkumar S V; Fonseca R
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):529-34.
-
2007: Ong H T; Hasegawa K; Dietz A B; Russell S J; Peng K-W
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
Gene therapy 2007;14(4):324-33.
-
2007: Iankov Ianko D; Blechacz Boris; Liu Chunsheng; Schmeckpeper Jeffrey D; Tarara James E; Federspiel Mark J; Caplice Noel; Russell Stephen J
Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(1):114-22.
-
2007: Dispenzieri Angela; Lacy Martha Q; Zeldenrust Steven R; Hayman Suzanne R; Kumar Shaji K; Geyer Susan M; Lust John A; Allred Jacob B; Witzig Thomas E; Rajkumar S Vincent; Greipp Philip R; Russell Stephen J; Kabat Brian; Gertz Morie A
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.
Blood 2007;109(2):465-70.
-
2006: Allen Cory; Vongpunsawad Sompong; Nakamura Takafumi; James C David; Schroeder Mark; Cattaneo Roberto; Giannini Caterina; Krempski James; Peng Kah-Whye; Goble Jenny M; Uhm Joon H; Russell Stephen J; Galanis Evanthia
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
Cancer research 2006;66(24):11840-50.
-
2006: Blechacz Boris; Splinter Patrick L; Greiner Suzanne; Myers Rae; Peng Kah-Whye; Federspiel Mark J; Russell Stephen J; LaRusso Nicholas F
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2006;44(6):1465-77.
-
2006: Carlson Stephanie K; Classic Kelly L; Hadac Elizabeth M; Bender Claire E; Kemp Bradley J; Lowe Val J; Hoskin Tanya L; Russell Stephen J
In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(6):324-32.
-
2006: Szécsi Judit; Drury Rosybel; Josserand Véronique; Grange Marie-Pierre; Boson Bertrand; Hartl Irene; Schneider Richard; Buchholz Christian J; Coll Jean-Luc; Russell Stephen J; Cosset François-Loïc; Verhoeyen Els
Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):735-44.
-
2006: Iankov Ianko D; Pandey Manoj; Harvey Mary; Griesmann Guy E; Federspiel Mark J; Russell Stephen J
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Journal of virology 2006;80(17):8530-40.
-
2006: McDonald Cari J; Erlichman Charles; Ingle James N; Rosales Gabriela A; Allen Cory; Greiner Suzanne M; Harvey Mary E; Zollman Paula J; Russell Stephen J; Galanis Evanthia
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer.
Breast cancer research and treatment 2006;99(2):177-84.
-
2006: Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Gollbach Kimberly L; Hayman Suzanne R; Kumar Shaji; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E; Zeldenrust Steven R; Dingli David; Bergsagel P Lief; Fonseca Rafael; Reeder Craig B; Stewart A Keith; Roy Vivek; Dalton Robert J; Carr Alan B; Kademani Deepak; Keller Eugene E; Viozzi Christopher F; Kyle Robert A
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
-
2006: Peng K-W; Hadac E M; Anderson B D; Myers R; Harvey M; Greiner S M; Soeffker D; Federspiel M J; Russell S J
Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model.
Cancer gene therapy 2006;13(8):732-8.
-
2006: Oi Keiji; Davies William R; Tazelaar Henry D; Bailey Kent R; Federspiel Mark J; Russell Stephen J; McGregor Christopher G A
Ex vivo hypothermic recirculatory adenoviral gene transfer to the transplanted pig heart.
The journal of gene medicine 2006;8(7):795-803.
-
2006: Merchan Jaime R; Tang Jian; Hu Guang; Lin Yanfeng; Mutter Walter; Tong Caili; Karumanchi S Ananth; Russell Stephen J; Sukhatme Vikas P
Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Journal of the National Cancer Institute 2006;98(11):756-64.
-
2006: Ong Hooi Tin; Timm Michael M; Greipp Philip R; Witzig Thomas E; Dispenzieri Angela; Russell Stephen J; Peng Kah-Whye
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells.
Experimental hematology 2006;34(6):713-20.
-
2006: Goel Apollina; Dispenzieri Angela; Geyer Susan M; Greiner Suzanne; Peng Kah-Whye; Russell Stephen J
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma.
Blood 2006;107(10):4063-70.
-
2006: Dispenzieri Angela; Lacy Martha Q; Katzmann Jerry A; Rajkumar S Vincent; Abraham Roshini S; Hayman Suzanne R; Kumar Shaji K; Clark Raynell; Kyle Robert A; Litzow Mark R; Inwards David J; Ansell Stephen M; Micallef Ivana M; Porrata Luis F; Elliott Michelle A; Johnston Patrick B; Greipp Philip R; Witzig Thomas E; Zeldenrust Steven R; Russell Stephen J; Gastineau Dennis; Gertz Morie A
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
-
2006: Hasegawa Kosei; Pham Linh; O'Connor Michael K; Federspiel Mark J; Russell Stephen J; Peng Kah-Whye
Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1868-75.
-
2006: Dingli David; Cascino Matthew D; Josic Kresimir; Russell Stephen J; Bajzer Zeljko
Mathematical modeling of cancer radiovirotherapy.
Mathematical biosciences 2006;199(1):55-78.
-
2006: Dingli David; Kemp Brad J; O'Connor Michael K; Morris John C; Russell Stephen J; Lowe Val J
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):16-23.
-
2005: Rajkumar S Vincent; Hayman Suzanne R; Lacy Martha Q; Dispenzieri Angela; Geyer Susan M; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Gertz Morie A
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
Blood 2005;106(13):4050-3.
-
2005: Dingli David; Peng Kah-Whye; Harvey Mary E; Vongpunsawad Sompong; Bergert Elizabeth R; Kyle Robert A; Cattaneo Roberto; Morris John C; Russell Stephen J
Interaction of measles virus vectors with Auger electron emitting radioisotopes.
Biochemical and biophysical research communications 2005;337(1):22-9.
-
2005: Dwyer Roisin M; Schatz Stephen M; Bergert Elizabeth R; Myers Rae M; Harvey Mary E; Classic Kelly L; Blanco Michael C; Frisk Craig S; Marler Ronald J; Davis Brian J; O'Connor Michael K; Russell Stephen J; Morris John C
A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(5):835-41.
-
2005: Goel Apollina; Dispenzieri Angela; Greipp Philip R; Witzig Thomas E; Mesa Ruben A; Russell Stephen J
PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis.
Experimental hematology 2005;33(7):784-95.
-
2005: Myers Rae; Greiner Suzanne; Harvey Mary; Soeffker Diane; Frenzke Marie; Abraham Katalin; Shaw Alan; Rozenblatt Shmuel; Federspiel Mark J; Russell Stephen J; Peng Kah-Whye
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer.
Cancer gene therapy 2005;12(7):593-9.
-
2005: Hallak Louay K; Merchan Jaime R; Storgard Chris M; Loftus Joseph C; Russell Stephen J
Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression.
Cancer research 2005;65(12):5292-300.
-
2005: Hartl I; Schneider R M; Sun Y; Medvedovska J; Chadwick M P; Russell S J; Cichutek K; Buchholz C J
Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells.
Gene therapy 2005;12(11):918-26.
-
2005: Nakamura Takafumi; Peng Kah-Whye; Harvey Mary; Greiner Suzanne; Lorimer Ian A J; James Charles D; Russell Stephen J
Rescue and propagation of fully retargeted oncolytic measles viruses.
Nature biotechnology 2005;23(2):209-14.
-
2004: Dingli David; Bergert Elizabeth R; Bajzer Zeljko; O'connor Michael K; Russell Stephen J; Morris John C
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter.
Biochemical and biophysical research communications 2004;325(1):157-66.
-
2004: Hadac Elizabeth M; Peng Kah-Whye; Nakamura Takafumi; Russell Stephen J
Reengineering paramyxovirus tropism.
Virology 2004;329(2):217-25.
-
2004: Allen Cory; McDonald Cari; Giannini Caterina; Peng Kah Whye; Rosales Gabriela; Russell Stephen J; Galanis Evanthia
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
The journal of gene medicine 2004;6(11):1216-27.
-
2004: Nakamura Takafumi; Russell Stephen J
Oncolytic measles viruses for cancer therapy.
Expert opinion on biological therapy 2004;4(10):1685-92.
-
2004: Zhang Jie; Frolov Ilya; Russell Stephen J
Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
The journal of gene medicine 2004;6(10):1082-91.
-
2004: Peng K-W; Holler P D; Orr B A; Kranz D M; Russell S J
Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor.
Gene therapy 2004;11(15):1234-9.
-
2004: Blechacz Boris; Russell Stephen J
Parvovirus vectors: use and optimisation in cancer gene therapy.
Expert reviews in molecular medicine 2004;6(16):1-24.
-
2004: Anderson Bambi D; Nakamura Takafumi; Russell Stephen J; Peng Kah-Whye
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
Cancer research 2004;64(14):4919-26.
-
2004: Doran Patrick M; Turner Russell T; Chen David; Facteau Suzanne M; Ludvigson Jill M; Khosla Sundeep; Riggs B Lawrence; Russell Stephen J
Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.
Experimental hematology 2004;32(4):351-9.
-
2004: Nakamura Takafumi; Peng Kah-Whye; Vongpunsawad Sompong; Harvey Mary; Mizuguchi Hiroyuki; Hayakawa Takao; Cattaneo Roberto; Russell Stephen J
Antibody-targeted cell fusion.
Nature biotechnology 2004;22(3):331-6.
-
2004: Dingli David; Peng Kah-Whye; Harvey Mary E; Greipp Philip R; O'Connor Michael K; Cattaneo Roberto; Morris John C; Russell Stephen J
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.
Blood 2004;103(5):1641-6.
-
2003: Dingli David; Russell Stephen J; Morris John C
In vivo imaging and tumor therapy with the sodium iodide symporter.
Journal of cellular biochemistry 2003;90(6):1079-86.
-
2003: Russell Stephen J; Peng Kah-Whye
Primer on medical genomics. Part X: Gene therapy.
Mayo Clinic proceedings. Mayo Clinic 2003;78(11):1370-83.
-
2003: Peng Kah-Whye; Frenzke Marie; Myers Rae; Soeffker Diane; Harvey Mary; Greiner Suzanne; Galanis Evanthia; Cattaneo Roberto; Federspiel Mark J; Russell Stephen J
Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice.
Human gene therapy 2003;14(16):1565-77.
-
2003: Khare Pranay D; Rosales Ana G; Bailey Kent R; Russell Stephen J; Federspiel Mark J
Epitope selection from an uncensored peptide library displayed on avian leukosis virus.
Virology 2003;315(2):313-21.
-
2003: Khare Pranay D; Russell Stephen J; Federspiel Mark J
Avian leukosis virus is a versatile eukaryotic platform for polypeptide display.
Virology 2003;315(2):303-12.
-
2003: Russell Stephen J
Rise of the nanomachines.
Nature biotechnology 2003;21(8):872-3.
-
2003: Schneider R M; Medvedovska Y; Hartl I; Voelker B; Chadwick M P; Russell S J; Cichutek K; Buchholz C J
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases.
Gene therapy 2003;10(16):1370-80.
-
2003: Dingli David; Diaz Rosa Maria; Bergert Elizabeth R; O'Connor Michael K; Morris John C; Russell Stephen J
Genetically targeted radiotherapy for multiple myeloma.
Blood 2003;102(2):489-96.
-
2003: Phuong Loi K; Allen Cory; Peng Kah-Whye; Giannini Caterina; Greiner Suzanne; TenEyck Cynthia J; Mishra Prasanna K; Macura Slobodan I; Russell Stephen J; Galanis Evanthia C
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Cancer research 2003;63(10):2462-9.
-
2003: Johnson K J; Peng K-W; Allen C; Russell S J; Galanis E
Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Gene therapy 2003;10(9):725-32.
-
2003: Caplice Noel M; Bunch T Jared; Stalboerger Paul G; Wang Shaohua; Simper David; Miller Dylan V; Russell Stephen J; Litzow Mark R; Edwards William D
Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(8):4754-9.
-
2003: Peng Kah-Whye; Donovan Kathleen A; Schneider Urs; Cattaneo Roberto; Lust John A; Russell Stephen J
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.
Blood 2003;101(7):2557-62.
-
2003: Khurana V G; Weiler D A; Witt T A; Smith L A; Kleppe L S; Parisi J E; Simari R D; O'Brien T; Russell S J; Katusic Z S
A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues.
Gene therapy 2003;10(5):443-52.
-
2003: Sandrin V; Russell S J; Cosset F L
Targeting retroviral and lentiviral vectors.
Current topics in microbiology and immunology 2003;281():137-78.
-
2002: Russell Stephen J
RNA viruses as virotherapy agents.
Cancer gene therapy 2002;9(12):961-6.
-
2002: Dingli David; Timm Michael; Russell Stephen J; Witzig Thomas E; Rajkumar S Vincent
Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3948-54.
-
2002: Peng Kah-Whye; TenEyck Cynthia J; Galanis Evanthia; Kalli Kimberly R; Hartmann Lynn C; Russell Stephen J
Intraperitoneal therapy of ovarian cancer using an engineered measles virus.
Cancer research 2002;62(16):4656-62.
-
2002: Sanz L; Kristensen P; Blanco B; Facteau S; Russell S J; Winter G; Alvarez-Vallina L
Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices.
Gene therapy 2002;9(15):1049-53.
-
2002: Rajkumar S Vincent; Mesa Ruben A; Fonseca Rafael; Schroeder Georgene; Plevak Matthew F; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Russell Stephen J; Greipp Philip R
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
-
2002: Peng Kah-Whye; Facteau Suzanne; Wegman Troy; O'Kane Dennis; Russell Stephen J
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides.
Nature medicine 2002;8(5):527-31.
-
2002: Maurice Marielle; Verhoeyen Els; Salmon Patrick; Trono Didier; Russell Stephen J; Cosset François-Loïc
Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.
Blood 2002;99(7):2342-50.
-
2002: Larochelle A; Peng K W; Russell S J
Lentiviral vector targeting.
Current topics in microbiology and immunology 2002;261():143-63.
-
2001: Lavillette D; Russell S J; Cosset F L
Retargeting gene delivery using surface-engineered retroviral vector particles.
Current opinion in biotechnology 2001;12(5):461-6.
-
2001: Peng K W; Pham L; Ye H; Zufferey R; Trono D; Cosset F L; Russell S J
Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.
Gene therapy 2001;8(19):1456-63.
-
2001: Russell S J; Gonzalez F; Joshua-Tor L; Johnston S A
Selective chemical inactivation of AAA proteins reveals distinct functions of proteasomal ATPases.
Chemistry & biology 2001;8(10):941-50.
-
2001: Grote D; Russell S J; Cornu T I; Cattaneo R; Vile R; Poland G A; Fielding A K
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.
Blood 2001;97(12):3746-54.
-
2001: Galanis E; Bateman A; Johnson K; Diaz R M; James C D; Vile R; Russell S J
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Human gene therapy 2001;12(7):811-21.
-
2001: Lavillette D; Boson B; Russell S J; Cosset F L
Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Journal of virology 2001;75(8):3685-95.
-
2001: Pham L; Ye H; Cosset F L; Russell S J; Peng K W
Concentration of viral vectors by co-precipitation with calcium phosphate.
The journal of gene medicine 2001;3(2):188-94.
-
2001: Hammond A L; Plemper R K; Zhang J; Schneider U; Russell S J; Cattaneo R
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen.
Journal of virology 2001;75(5):2087-96.
-
2000: Schneider U; Bullough F; Vongpunsawad S; Russell S J; Cattaneo R
Recombinant measles viruses efficiently entering cells through targeted receptors.
Journal of virology 2000;74(21):9928-36.
-
2000: Diaz R M; Bateman A; Emiliusen L; Fielding A; Trono D; Russell S J; Vile R G
A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.
Gene therapy 2000;7(19):1656-63.
-
2000: Fielding A K; Chapel-Fernandes S; Chadwick M P; Bullough F J; Cosset F L; Russell S J
A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Human gene therapy 2000;11(6):817-26.
-
2000: Bateman A; Bullough F; Murphy S; Emiliusen L; Lavillette D; Cosset F L; Cattaneo R; Russell S J; Vile R G
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.
Cancer research 2000;60(6):1492-7.
-
2000: Hatziioannou T; Russell S J; Cosset F L
Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Virology 2000;267(1):49-57.
-
2000: Vile R G; Russell S J; Lemoine N R
Cancer gene therapy: hard lessons and new courses.
Gene therapy 2000;7(1):2-8.
-
2000: Lavillette D; Ruggieri A; Russell S J; Cosset F L
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.
Journal of virology 2000;74(1):295-304.
-
1999: Russell S J; Cosset F L
Modifying the host range properties of retroviral vectors.
The journal of gene medicine 1999;1(5):300-11.
-
1999: Maurice M; Mazur S; Bullough F J; Salvetti A; Collins M K; Russell S J; Cosset F L
Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
Blood 1999;94(2):401-10.
-
1999: Hatziioannou T; Delahaye E; Martin F; Russell S J; Cosset F L
Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.
Human gene therapy 1999;10(9):1533-44.
-
1999: Chadwick M P; Morling F J; Cosset F L; Russell S J
Modification of retroviral tropism by display of IGF-I.
Journal of molecular biology 1999;285(2):485-94.
-
1998: Lavillette D; Maurice M; Roche C; Russell S J; Sitbon M; Cosset F L
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
Journal of virology 1998;72(12):9955-65.
-
1998: Buchholz C J; Peng K W; Morling F J; Zhang J; Cosset F L; Russell S J
In vivo selection of protease cleavage sites from retrovirus display libraries.
Nature biotechnology 1998;16(10):951-4.
-
1998: Hatziioannou T; Valsesia-Wittmann S; Russell S J; Cosset F L
Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses.
Journal of virology 1998;72(6):5313-7.
-
1998: Fielding A K; Maurice M; Morling F J; Cosset F L; Russell S J
Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells.
Blood 1998;91(5):1802-9.
-
1997: Morling F J; Peng K W; Cosset F L; Russell S J
Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Virology 1997;234(1):51-61.
-
1997: Peng K W; Morling F J; Cosset F L; Murphy G; Russell S J
A gene delivery system activatable by disease-associated matrix metalloproteinases.
Human gene therapy 1997;8(6):729-38.
-
1997: Valsesia-Wittmann S; Morling F J; Hatziioannou T; Russell S J; Cosset F L
Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
The EMBO journal 1997;16(6):1214-23.
-
1996: Cosset F L; Russell S J
Targeting retrovirus entry.
Gene therapy 1996;3(11):946-56.
-
1996: Ager S; Nilson B H; Morling F J; Peng K W; Cosset F L; Russell S J
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.
Human gene therapy 1996;7(17):2157-64.
-
1996: Nilson B H; Morling F J; Cosset F L; Russell S J
Targeting of retroviral vectors through protease-substrate interactions.
Gene therapy 1996;3(4):280-6.
-
1996: Valsesia-Wittmann S; Morling F J; Nilson B H; Takeuchi Y; Russell S J; Cosset F L
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Journal of virology 1996;70(3):2059-64.
-
1995: Cosset F L; Morling F J; Takeuchi Y; Weiss R A; Collins M K; Russell S J
Retroviral retargeting by envelopes expressing an N-terminal binding domain.
Journal of virology 1995;69(10):6314-22.
-
1995: Morling F J; Russell S J
Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate.
Gene therapy 1995;2(7):504-8.
-
1993: Hawkins R E; Winter G; Hamblin T J; Stevenson F K; Russell S J
A genetic approach to idiotypic vaccination.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(4):273-8.
-
1992: Hawkins R E; Russell S J; Winter G
Selection of phage antibodies by binding affinity. Mimicking affinity maturation.
Journal of molecular biology 1992;226(3):889-96.
Sign-in to see more
